Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Oncolytics Biotech Inc ONCY


Primary Symbol: T.ONC

Oncolytics Biotech Inc. is a clinical-stage biotechnology company. The Company is focused on developing pelareorep, an intravenously delivered immunotherapeutic agent that activates the innate and adaptive immune systems and weakens tumor defense mechanisms. This compound induces anti-cancer immune responses and promotes an inflamed tumor phenotype turning cold tumors hot through innate and adaptive immune responses to treat a variety of cancers. This improves the ability of the immune system to fight cancer, making tumors more susceptible to a broad range of oncology treatments. The Company’s primary focus is to advance its programs in hormone receptor-positive / human epidermal growth factor 2- negative (HR+/HER2-) metastatic breast cancer and advanced/metastatic pancreatic ductal adenocarcinoma to registration-enabling clinical studies. In addition, it is exploring opportunities for registrational programs in other gastrointestinal cancers through its GOBLET platform study.


TSX:ONC - Post by User

Post by jh1970on Dec 16, 2023 10:12am
284 Views
Post# 35788157

New hiring position

New hiring position

Senior Medical Writer

Reporting To:

Chief Medical Officer

Location:

Calgary, Alberta or San Diego, California (Office-Based)

Summary:

This position supports Oncolytics’ Clinical Development, Clinical Operations and Regulatory Affairs teams in writing and coordinating the writing and review of technical documents for the Company

Key Responsibilities:

The Senior Medical Writer is responsible for the development and management of medical writing deliverables in support of key Oncolytics functions including Clinical Development, Clinical Operations, and Regulatory Affairs.

The specific responsibilities of this role include, but are not limited to:

  • Serve as the primary writer for a range of medical writing projects including the design, planning, and preparation of documents supporting clinical development (e.g., study protocols, study reports, investigator brochures, etc.), regulatory activities (e.g., briefing materials, clinical modules, etc.), and manuscript preparation.
  • Ensure that documents are high-quality in terms of scientific content, organization, clarity, accuracy, format, consistency, and adherence to relevant internal and external (e.g., regulatory) guidelines.
  • Review, edit, and ensure the quality of documents prepared by other medical writers (internal or external) and functional area representatives.
  • Ensure that medical writing activities are coordinated with other departments, including Regulatory Affairs, Clinical Development, Pharmacovigilance, etc., and that timelines are met.
  • Ensure consistent messaging across documents (nonclinical, clinical, regulatory, etc.).
  • Oversee and coordinate the activities of contract writers engaged by Oncolytics.
  • Work collaboratively with colleagues in other departments (e.g., Clinical Development, Clinical Operations, Regulatory Affairs, Statistics/Data Management, Pharmacovigilance, etc.).
  • Help maintain the Trial Master File and ensure it is current.
  • Train and mentor junior writers and work closely with other members of the Oncolytics’ Medical Writing team.
  • Other tasks as required

Qualifications:

  • Excellent written and oral communication skills.
  • Well-developed organizational skills, thorough with excellent attention to detail.
  • Strong analytical and problem-solving ability, innovative and creative, good judgment; ability to identify risks to timelines and data
  • Self-motivated with the ability to work both independently and collaboratively as a member of a team; good leadership
  • Knowledge and understanding of FDA and ICH guidelines, Good Clinical Practices (GCP), medical terminology, clinical trial methodology, and drug development processes.
  • Oncology drug development experience desirable but not required.
  • Able to travel domestically and internationally approximately 2-3 times a year if required.

Education & Experience:

  • A bachelor’s degree, preferably in a scientific or technical discipline, is required.
  • A minimum of 3-5 years of previous professional medical writing experience in a pharmaceutical, biotechnology or medical-related

To apply, please provide a resume and cover letter to careers@oncolyticsbiotech.com 


<< Previous
Bullboard Posts
Next >>